OxySure (OXYS) Inks Distribution Agreement with Stop Heart Attack
Frisco, Texas, February 18, 2015 – OxySure Systems, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today announced that the Company has signed a distribution agreement with Stop Heart Attack of Birmingham, Alabama.
“Stop Heart Attack gives us strong representation in the Southeast”, said Clark Hood, VP of Resuscitation Sales for OxySure. “Floyd brings decades of experience in the field of defibrillation, as well as other emergency response products. His vast experience and strong contacts throughout the Southeast and across the U.S. will strengthen OxySure’s continued growth and expansion in the North America market. By adding the Model 615 portable oxygen device to their portfolio, they now can offer a unique and proprietary resuscitation product to their existing and new customers.”
“We are excited to sign this distribution contract with OxySure Systems, Inc.,” said Floyd Larkin, President/CEO and Founder of Stop Heart Attack. “The Model 615 device is FDA approved for OTC (over the counter) use and thus requires no prescription. This makes it ideal for the lay person responder and a perfect companion product to an AED program. We can now offer a viable solution to our customers, which will make the administration of emergency oxygen simple, safe and more accessible in the education and work environment.”
The website for Stop Heart Attack can be found at www.stopheartattack.com/
About OxySure Systems, Inc.
OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments. www.OxySure.com
Forward-Looking Statements
Statements in this earnings release that are not historical facts are considered to be forward-looking statements. Such statements include, but are not limited to, statements regarding management beliefs and expectations, based upon information available at the time the statements are made, regarding future plans, objectives and performance. All forward-looking statements are subject to risks and uncertainties, many of which are beyond management’s control and actual results and performance may differ significantly from those contained in forward-looking statements. OxySure Systems, Inc. intends any forward-looking statement to be covered by the Litigation Reform Act of 1995 and is including this statement for purposes of said safe harbor provisions. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this news release. OxySure Systems, Inc. undertakes no obligation to update any forward-looking statements to reflect events or circumstances that occur after the date as of which such statements are made. A discussion of certain risks and uncertainties that could cause actual results to differ materially from those contained in forward-looking statements is included in OxySure Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2013.
Investor Contacts:
Renmark Financial Communications, Inc.
Bettina Filippone: bfilippone@renmarkfinancial.com
John Boidman: jboidman@renmarkfinancial.com
Tel.: (416) 644-2020 or (514) 939-3989
Redchip Companies, Inc.
Jon Cunningham: jon@redchip.com
800-733-2447, ext. 107
Tags: